Medable Brings Digital Trial Platform to Google Cloud Marketplace
New partnership leverages Google’s infrastructure and artificial intelligence capabilities.
Medable has announced a collaboration with Google Cloud to bring its Digital and Decentralized Clinical Trial Platform to Google Cloud Marketplace. Customers of Medable will benefit from Google’s infrastructure and artificial intelligence capabilities with accelerated operations in clinical trial design, deployment, and management.1
In a press release, Michelle Longmire, MD co-founder and CEO of Medable said, “This alliance provides life sciences companies with Medable’s cutting-edge clinical development technology powered by Google Cloud through Google Cloud Marketplace. The collaboration will enable scaled and seamless adoption of Medable solutions by Google Cloud users, providing life sciences companies with platform capabilities proven to improve patient access to trials and accelerate critical development efforts, globally.”
In addition to its Digital and Decentralized Clinical Trial Platform, Medable’s newly launched Studio will integrate seamlessly with Google Cloud Marketplace.
“Bringing Medable’s platform to Google Cloud Marketplace will help customers quickly deploy, manage, and expand their use of the AI-driven clinical trial platform on Google Cloud's trusted, global infrastructure," Dai Vu, managing director, marketplace & ISV GTM programs at Google Cloud, said in the press release.
Medable Studio was introduced earlier in August. The application offers customers an all-in-one solution for electronic clinical outcome assessment (eCOA) management. It has capabilities in configuration, translation, and validation throughout the eCOA launch process. Customers of Studio can choose between self-service, full-service, or a combination of options.2
“Medable Studio upends the traditional study build/test/launch process by streamlining it using intelligence and automation,” Tim Smith, chief technology officer and co-founder, Medable, said in an earlier press release. “With Medable Studio, timelines shift from weeks and months to just days. Customers described Studio as a quantum leap in speed, scale, and quality, and it empowers sponsors with complete visibility and control over the entire process.”
Functions of Studio include:
- Point-and-Click Builder: Creates assessments, instruments, and diaries with features like no-code formatting, live preview, branching rules, and globalization support for translations.
- Visual Schedule of Assessments Builder: Adds assessments and instruments to a study schedule and configures standard visits, workflows and notifications, as well as unscheduled and remote visits.
- Translation Workbench: Manages translations and streamlines the sending and import processes.
- Content Library: Stores assessments, instruments, translations, and locales in one system.
In the press release, Longmire added, “This is just the start to transforming how evidence is generated. Medable Studio is where trial teams go to create. It allows for greater scalability, efficiency gains, and better, protocol-fit science. Studio will set new benchmarks for trial execution and ultimately advance our mission to enable effective therapies to reach patients faster by reducing trial start-up timelines and cost.”
References
1. Medable Joins Forces with Google Cloud to Deliver Digital Clinical Trials Technology on Google Cloud Marketplace. News release. Medable. October 30, 2024. Accessed November 1, 2024. https://www.businesswire.com/news/home/20241030519844/en/Medable-Joins-Forces-with-Google-Cloud-to-Deliver-Digital-Clinical-Trials-Technology-on-Google-Cloud-Marketplace
2. New Medable Studio Empowers Sponsors to Launch eCOA Solutions Into Clinical Trials With Unparalleled Control and Efficiency. News release. Medable. August 14, 2024. Accessed November 1, 2024. https://www.businesswire.com/news/home/20240814443065/en/New-Medable-Studio-Empowers-Sponsors-to-Launch-eCOA-Solutions-Into-Clinical-Trials-With-Unparalleled-Control-and-Efficiency
Phase III Trials Show Long-Term Efficacy of Cobenfy Treating Schizophrenia
November 1st 2024Cobenfy (xanomeline and trospium chloride) demonstrated sustained long-term efficacy, safety, and tolerability over 52 weeks in Phase III trials for adult schizophrenia patients, showing significant symptom improvement and quality of life benefits with minimal adverse effects.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
WCG Randomized 1,600 Participants for RSV Vaccine Trial
October 31st 2024A top 5 sponsor turned to WCG to recruit expecting mothers for its Phase III RSV vaccine trial. WCG support covered multiple countries and contributed almost one third of overall randomizations in the supported countries, bringing the study in ahead of schedule despite delays due to COVID-19 impacts on RSV seasonality. The sponsor met study timeline past enrollment by continuing to work with WCG’s retention support.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
WCG Meets Enrollment 24 Months Early for Top 5 Pharma’s Decentralized Trial
October 31st 2024A sponsor needed to get their Phase II dermatology study enrollment back on track. The study was underway for 11 months across 32 sites globally with only 20 subjects enrolled to date. With WCG support, enrollment was concluded 24 months ahead of schedule.
WCG Support Empowers Oncology Sites to Reach Full Potential
October 31st 2024A top 5 sponsor was falling behind on data entry for their global oncology portfolio, which included 130+ sites and 100+ protocols. WCG supported data entry and query resolution for 130+ sites, resolving data entry backlog in time for interim analyses.
